Literature DB >> 11943711

Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining.

Alan K Meeker1, Wesley R Gage, Jessica L Hicks, Inpakala Simon, Jonathan R Coffman, Elizabeth A Platz, Gerrun E March, Angelo M De Marzo.   

Abstract

A method was developed to assess human telomere lengths at the individual cell level in tissue sections from standard formalin-fixed paraffin-embedded tissues. We coupled this method with immunofluorescence to allow the simultaneous identification of specific cell types. Validation of this in situ quantification method showed excellent agreement with the commonly used telomere repeat fragment-Southern blot method. The assay requires very few cells ( approximately 10 to 15). Thus, small tissue samples, including clinical biopsies, can be easily accommodated. In addition, the cells under study need not be actively cycling and there is no requirement for tissue disaggregation or cell culture. This method provides a more accurate assessment of telomere lengths than Southern blotting because confounding contributions from undesired cell types within tissue samples are avoided. Using this technique, we were able to perform the first comparison of relative telomere lengths in matched tumor versus normal epithelial cells within archival human prostate tissues.

Entities:  

Mesh:

Year:  2002        PMID: 11943711      PMCID: PMC1867217          DOI: 10.1016/S0002-9440(10)62553-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  71 in total

1.  Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN).

Authors:  K S Koeneman; C X Pan; J K Jin; J M Pyle; R C Flanigan; T V Shankey; M O Diaz
Journal:  J Urol       Date:  1998-10       Impact factor: 7.450

Review 2.  Telomerase: a promising marker of biological immortality of germ, stem, and cancer cells. A review.

Authors:  A K Meeker; D S Coffey
Journal:  Biochemistry (Mosc)       Date:  1997-11       Impact factor: 2.487

3.  Origin of concatemeric T7 DNA.

Authors:  J D Watson
Journal:  Nat New Biol       Date:  1972-10-18

4.  Longevity, stress response, and cancer in aging telomerase-deficient mice.

Authors:  K L Rudolph; S Chang; H W Lee; M Blasco; G J Gottlieb; C Greider; R A DePinho
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

5.  Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis.

Authors:  E González-Suárez; E Samper; J M Flores; M A Blasco
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

6.  Extensive telomere repeat arrays in mouse are hypervariable.

Authors:  J A Starling; J Maule; N D Hastie; R C Allshire
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

Review 7.  Aging and cancer: are telomeres and telomerase the connection?

Authors:  J W Shay
Journal:  Mol Med Today       Date:  1995-11

8.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

9.  Telomerase activity: a prevalent marker of malignant human prostate tissue.

Authors:  H J Sommerfeld; A K Meeker; M A Piatyszek; G S Bova; J W Shay; D S Coffey
Journal:  Cancer Res       Date:  1996-01-01       Impact factor: 12.701

Review 10.  Telomeres and telomerase in aging and cancer.

Authors:  C B Harley; B Villeponteau
Journal:  Curr Opin Genet Dev       Date:  1995-04       Impact factor: 5.578

View more
  78 in total

1.  Telomere length variation in normal epithelial cells adjacent to tumor: potential biomarker for breast cancer local recurrence.

Authors:  Xin Zhou; Alan K Meeker; Kepher H Makambi; Ourania Kosti; Bhaskar V S Kallakury; Mary K Sidawy; Christopher A Loffredo; Yun-Ling Zheng
Journal:  Carcinogenesis       Date:  2011-11-09       Impact factor: 4.944

2.  Organ aging and susceptibility to cancer may be related to the geometry of the stem cell niche.

Authors:  Krastan B Blagoev
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

3.  Hepatocellular telomere length in biliary atresia measured by Q-FISH.

Authors:  Yukihiro Sanada; Junko Aida; Youichi Kawano; Ken-ichi Nakamura; Naotaka Shimomura; Naoshi Ishikawa; Tomio Arai; Steven S S Poon; Naoya Yamada; Noriki Okada; Taiichi Wakiya; Makoto Hayashida; Takeshi Saito; Satoshi Egami; Shuji Hishikawa; Yoshiyuki Ihara; Taizen Urahashi; Koichi Mizuta; Yoshikazu Yasuda; Hideo Kawarasaki; Kaiyo Takubo
Journal:  World J Surg       Date:  2012-04       Impact factor: 3.352

4.  Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis.

Authors:  Elisabetta Kuhn; Alan Meeker; Tian-Li Wang; Ann Smith Sehdev; Robert J Kurman; Ie-Ming Shih
Journal:  Am J Surg Pathol       Date:  2010-06       Impact factor: 6.394

5.  Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma.

Authors:  Elisabetta Kuhn; Alan K Meeker; Kala Visvanathan; Amy L Gross; Tian-Li Wang; Robert J Kurman; Ie-Ming Shih
Journal:  Mod Pathol       Date:  2011-04-15       Impact factor: 7.842

6.  PARP1 Is a TRF2-associated poly(ADP-ribose)polymerase and protects eroded telomeres.

Authors:  Marla Gomez; Jun Wu; Valérie Schreiber; John Dunlap; Françoise Dantzer; Yisong Wang; Yie Liu
Journal:  Mol Biol Cell       Date:  2006-01-25       Impact factor: 4.138

7.  The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.

Authors:  Donald J Vander Griend; Wouter L Karthaus; Susan Dalrymple; Alan Meeker; Angelo M DeMarzo; John T Isaacs
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

8.  Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells.

Authors:  Mindy K Graham; Jiyoung Kim; Joseph Da; Jacqueline A Brosnan-Cashman; Anthony Rizzo; Javier A Baena Del Valle; Lionel Chia; Michael Rubenstein; Christine Davis; Qizhi Zheng; Leslie Cope; Michael Considine; Michael C Haffner; Angelo M De Marzo; Alan K Meeker; Christopher M Heaphy
Journal:  Mol Cancer Res       Date:  2019-10-14       Impact factor: 5.852

Review 9.  Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling.

Authors:  Mukesh Verma; Muin J Khoury; John P A Ioannidis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-14       Impact factor: 4.254

10.  The longest telomeres: a general signature of adult stem cell compartments.

Authors:  Ignacio Flores; Andres Canela; Elsa Vera; Agueda Tejera; George Cotsarelis; María A Blasco
Journal:  Genes Dev       Date:  2008-02-18       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.